Coronavirus: US Planning To Treat Severely Sick Covid-19 Patients With Remdesivir
Covid-19: Gilead’s Antiviral Drug Remdesivir Said To Have Flopped In First Clinical Trial But Company Disputes Results
Shares Of Gilead Sciences Surge After Clinical Trial Suggest That Remdesivir Helped Covid-19 Patients Recover Quickly
Remdesivir: Two-Thirds of Severe Coronavirus Patients Improved After Receiving The Drug During A Limited Trial
Three Coronavirus Vaccine Candidates That Show Promise
Gilead Sciences Commences Clinical Trial Of Remdesivir, The Most Promising Antiviral Drug So Far To Treat Coronavirus
